Maria Y. Giovanni
Assistant Director for Microbial Genomics & Advanced Technology
Sequencing projects will be selected by NIAID, based on NIAID programmatic priorities, national priorities, cost considerations, available funds, sequencing capacities of the three centers, availability of source of DNA, and input from the Genomic Sequencing Centers of Infectious Disease (GSC) Working Group. Levels of priority (high, medium, and low) for the sequencing project will be determined; the process will not involve the National Institutes of Health (NIH) peer review system.
It is anticipated that the review process will be completed within four to six weeks of the proposal receipt deadline. NIAID may revise this timeline if the number of proposals is more than expected or if other program priorities take precedence. Investigators will be notified electronically by NIAID or the sequencing center about the status of their sequencing projects.
Investigators wishing to apply for support to sequence an organism not described above must do so in the context of an investigator-initiated, hypothesis-driven, unsolicited research project application (R01), subject to standard NIH acceptance and peer-review procedures. NIAID will only accept such applications for review that contain a substantial research component beyond genome sequencing.
Once the sequencing project is reviewed and selected, NIAID will select the NIAID GSC to perform the sequencing.
Last Updated December 06, 2012